Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry.

Sajed Mangoo,Simon Erridge,Carl Holvey,Ross Coomber,Daniela A Riano Barros,Urmila Bhoskar,Gracia Mwimba,Kavita Praveen,Chris Symeon,Simmi Sachdeva-Mohan,James J Rucker,Mikael H Sodergren

Expert review of neurotherapeutics（2022）

引用 4|浏览2

暂无评分

摘要

CBMP treatment was associated with reductions in depression severity at 1, 3, and 6 months. Limitations of the study design mean that a causal relationship cannot be proven. This analysis provides insights for further study within clinical trial settings.

查看译文

关键词

cannabidiol,depression,medicinal cannabis,tetrahydrocannabinol

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要